Predict your next investment

Venture Capital
crabtreeventures.net

See what CB Insights has to offer

Investments

16

Portfolio Exits

3

About Crabtree Ventures

Crabtree Ventures, L.P. is a $15 million early-stage venture capital fund targeted at applications of mathematical ideas in the life sciences and other industries. In addition to making equity investments at the Series A & B rounds, Crabtree's General Partner provides strategy and business-building skills. Investments to date: Novasite Pharmaceuticals; Applied Molecular Evolution; Blue Heron Biotechnology; Confer Software; and Hynomics Corporation.

Crabtree Ventures Headquarter Location

790 West Frontage Road

Northfield, Illinois, 60093,

United States

847 441-4240

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Crabtree Ventures Investments

16 Investments

Crabtree Ventures has made 16 investments. Their latest investment was in Minute Molecular as part of their Unattributed VC - II on November 11, 2019.

CBI Logo

Crabtree Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/22/2019

Unattributed VC - II

Minute Molecular

$0.8M

No

1

10/23/2018

Series G - II

Biodesix

$17.51M

No

2

8/13/2018

Unattributed VC

Minute Molecular

$1.09M

Yes

1

7/16/2018

Series G

Subscribe to see more

$99M

Subscribe to see more

10

5/8/2018

Convertible Note - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/22/2019

10/23/2018

8/13/2018

7/16/2018

5/8/2018

Round

Unattributed VC - II

Series G - II

Unattributed VC

Series G

Convertible Note - III

Company

Minute Molecular

Biodesix

Minute Molecular

Subscribe to see more

Subscribe to see more

Amount

$0.8M

$17.51M

$1.09M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

2

1

10

10

Crabtree Ventures Portfolio Exits

3 Portfolio Exits

Crabtree Ventures has 3 portfolio exits. Their latest portfolio exit was Biodesix on October 28, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/28/2020

IPO

$99M

Public

3

8/13/2010

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

6/14/2001

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/28/2020

8/13/2010

6/14/2001

Exit

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

3

0

0

Crabtree Ventures Team

1 Team Member

Crabtree Ventures has 1 team member, including current Founder, Jack Schuler.

Name

Work History

Title

Status

Jack Schuler

Founder

Current

Name

Jack Schuler

Work History

Title

Founder

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.